SCHEMBL2637513

SCHEMBL2637513

Nc1c(=O)[nH]n2c(=O)cc(-c3cccc(Cl)c3)[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
DHFR P00374 1/20 0.43
BRD4 O60885 1/20 0.43
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
HTT P42858 1/20 0.40
KDM5B Q9UGL1 2/20 0.40
PSD A5PKW4 1/20 0.39
KDM4A O75164 1/20 0.39
KDM5A P29375 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
LDHA P00338 1/20 0.38
TYMP P19971 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637972 0.78 MEN1 (0.41) NPC1RAB9AMEN1KMT2ADHFR
SCHEMBL2637509 0.77 HSP90AA1 (0.44) NPC1RAB9AMEN1KMT2ABRD4
SCHEMBL2637795 0.76 MEN1 (0.44) NPC1RAB9AMEN1KMT2ADHFR
SCHEMBL2637207 0.75 CNR2 (0.45) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL2637478 0.75 HSP90AA1 (0.47) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL2637603 0.75 ALOX5 (0.48) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL2637716 0.74 KMT2A (0.47) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL2637501 0.74 NUDT1 (0.44) NPC1RAB9AMEN1KMT2AHPGD
SCHEMBL2637663 0.73 PGR (0.42) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL2637666 0.73 POLB (0.43) NPC1RAB9AMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed